Xie C, Huang X, Li R, Tsodikov A, Bhalla K
Ann Appl Stat. 2025; 18(4):2796-2817.
PMID: 40017565
PMC: 11864788.
DOI: 10.1214/24-aoas1906.
Omer M, Mustafa M, Ali N, Abd Rahman N
Asian Pac J Cancer Prev. 2023; 24(12):4167-4177.
PMID: 38156852
PMC: 10909084.
DOI: 10.31557/APJCP.2023.24.12.4167.
Pan C, Cai B, Sui X
Lifetime Data Anal. 2023; 30(2):327-344.
PMID: 38015378
DOI: 10.1007/s10985-023-09613-8.
Clarence Safari W, Lopez-de-Ullibarri I, Jacome M
Lifetime Data Anal. 2023; 29(3):608-627.
PMID: 36890338
PMC: 9994787.
DOI: 10.1007/s10985-023-09591-x.
Xie C, Huang X, Li R, Pisters P
Stat Med. 2022; 41(29):5698-5714.
PMID: 36165535
PMC: 9691595.
DOI: 10.1002/sim.9588.
Analysis of survival data with cure fraction and variable selection: A pseudo-observations approach.
Su C, Chiou S, Lin F, Platt R
Stat Methods Med Res. 2022; 31(11):2037-2053.
PMID: 35754373
PMC: 9660265.
DOI: 10.1177/09622802221108579.
Application of non-parametric models for analyzing survival data of COVID-19 patients.
Ghosh S, Samanta G, Nieto J
J Infect Public Health. 2021; 14(10):1328-1333.
PMID: 34479820
PMC: 8393507.
DOI: 10.1016/j.jiph.2021.08.025.
Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US.
Wang Y, Rui M, Yang L, Wang X, Shang Y, Ma A
Front Public Health. 2021; 9:650392.
PMID: 33889559
PMC: 8055835.
DOI: 10.3389/fpubh.2021.650392.
Life expectancy improvement for multiple cure distributions.
Naik S, Adamic P
Eur Actuar J. 2020; 10(1):73-90.
PMID: 32626640
PMC: 7319305.
DOI: 10.1007/s13385-020-00229-y.
Semiparametric sieve maximum likelihood estimation under cure model with partly interval censored and left truncated data for application to spontaneous abortion.
Wu Y, Chambers C, Xu R
Lifetime Data Anal. 2018; 25(3):507-528.
PMID: 30014201
PMC: 6335201.
DOI: 10.1007/s10985-018-9445-4.
Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.
Baghestani A, Shahmirzalou P, Sayad S, Akbari M, Zayeri F
Asian Pac J Cancer Prev. 2018; 19(6):1601-1606.
PMID: 29936785
PMC: 6103589.
DOI: 10.22034/APJCP.2018.19.6.1601.
A class of semiparametric cure models with current status data.
Diao G, Yuan A
Lifetime Data Anal. 2018; 25(1):26-51.
PMID: 29423775
PMC: 6082745.
DOI: 10.1007/s10985-018-9420-0.
Inference in a survival cure model with mismeasured covariates using a simulation-extrapolation approach.
Bertrand A, Legrand C, Carroll R, de Meester C, Van Keilegom I
Polit Anal. 2017; 104(1):31-50.
PMID: 29151774
PMC: 5693403.
DOI: 10.1093/biomet/asw054.
A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.
Jonas S, Mbogning C, Hassler S, Broet P
PLoS One. 2017; 12(6):e0179896.
PMID: 28665947
PMC: 5493340.
DOI: 10.1371/journal.pone.0179896.
Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.
Gupta C, Cobre J, Polpo A, Sinha D
Biom J. 2016; 58(5):1164-77.
PMID: 27162061
PMC: 7314573.
DOI: 10.1002/bimj.201500111.
Variable selection in a flexible parametric mixture cure model with interval-censored data.
Scolas S, El Ghouch A, Legrand C, Oulhaj A
Stat Med. 2015; 35(7):1210-25.
PMID: 26467904
PMC: 5057324.
DOI: 10.1002/sim.6767.
Efficient semiparametric estimation of short-term and long-term hazard ratios with right-censored data.
Diao G, Zeng D, Yang S
Biometrics. 2013; 69(4):840-9.
PMID: 24328712
PMC: 3868993.
DOI: 10.1111/biom.12097.
Joint Modeling of Longitudinal and Cure-survival Data.
Kim S, Zeng D, Li Y, Spiegelman D
J Stat Theory Pract. 2013; 7(2):324-344.
PMID: 23926445
PMC: 3733282.
DOI: 10.1080/15598608.2013.772036.
A model-based statistic for detecting molecular markers associated with complex survival patterns in early-stage cancer.
Broet P, Moreau T
J Clin Bioinforma. 2012; 2(1):14.
PMID: 22866759
PMC: 3553048.
DOI: 10.1186/2043-9113-2-14.
Semiparametric Efficient Estimation for a Class of Generalized Proportional Odds Cure Models.
Mao M, Wang J
J Am Stat Assoc. 2012; 105(489):302-311.
PMID: 22865944
PMC: 3410987.
DOI: 10.1198/jasa.2009.tm08459.